Oubari Pharma

Slovakia
Lysá pod Makytou, Trenčín Region, Slovakia
+963 21 5788980 ★

Company profile

Oubari Pharma company profile

Oubari Pharma manufactures and markets generic pharmaceuticals across multiple therapeutic areas. The portfolio includes Zolpim (zolpidem tartrate) for short‑term treatment of insomnia, Glitom (miglitol) for management of type 2 diabetes, lincomycin formulations for serious infections, and analgesics indicated for mild to moderate pain. Operations include sterile manufacturing alongside oral solid dosage forms, supported by internal quality control and regulatory processes. Activities span formulation development, production of finished medicines, and publication of product information on indications, dosage, and administration. Dosage strengths and presentations vary by product as listed in official leaflets. Products are distributed under the Oubari brand.

Business identity

Contact email
[email protected]
Phone number
+963 21 5788980
Operating status
Active
Company type
For Profit
Employee range
00501-01000 employees
Revenue range
$50K+
Founded
1989-01-01

Headquarters

Headquarters
Lysá pod Makytou, Trenčín Region, Slovakia
Country code
SK
Continent
Europe

Capital profile

Funding and company signals

No public funding data is available for this company.

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.